Menu

PSMA and Beyond 2026: Clinical Trial Updates: DORA and PEACE-3 – Evolving Role of Radium-223

Article |

StrataLynx 2mo ago
PSMA and Beyond 2026: Clinical Trial Updates: DORA and PEACE-3 – Evolving Role of Radium-223

Michael Morris, MD, discussed DORA and PEACE-3 and the evolving role of radium-223 for metastatic castration resistant prostate cancer.

Comments (0)

Newest

No comments yet.